Search

Search Results
Results 1221 - 1230 of 1413 for chronic pain syndrome
  • News - 25 Feb 2010
    EpiCept Corporation today announced operating and financial results for the fourth quarter and year ended December 31, 2009, and provided an update on Ceplene® and several of the Company’s key product...
  • Drug - 14 Nov 2024
    Consumer Medicine Information (CMI) about Diclofenac Sodium Viatris (formerly Fenac) (diclofenac sodium) intended for persons living in Australia.
  • Drug - 12 Nov 2024
    Consumer Medicine Information (CMI) about Nuvigil (TB) (Armodafinil) intended for persons living in Australia.
  • Drug - 12 Nov 2024
    Consumer Medicine Information (CMI) about Besponsa intended for persons living in Australia.
  • Drug - 12 Nov 2024
    Consumer Medicine Information (CMI) about Monofer intended for persons living in Australia.
  • Drug - 28 Oct 2024
    Consumer Medicine Information (CMI) about Plaquenil intended for persons living in Australia.
  • Drug - 15 Oct 2024
    Consumer Medicine Information (CMI) about Proquad intended for persons living in Australia.
  • Drug - 14 Oct 2024
    Consumer Medicine Information (CMI) about Velsipity intended for persons living in Australia.
  • Drug - 4 Oct 2024
    Consumer Medicine Information (CMI) about Sohonos intended for persons living in Australia.
  • Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Opsynvi intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.